Search results
DaVita's (NYSE:DVA) three-year earnings growth trails the 15% YoY shareholder returns
Simply Wall St. via Yahoo Finance· 2 years agoBy buying an index fund, you can roughly match the market return with ease. But if you choose...
Here's Why You Should Add DaVita (DVA) to Your Portfolio
Zacks via Yahoo Finance· 2 months agoDaVita Inc. DVA has been gaining from its business model. The optimism led by a solid fourth-quarter...
DaVita (DVA) to Report Q3 Earnings: What's in the Offing?
Zacks via Yahoo Finance· 7 months agoDaVita Inc. DVA is scheduled to release third-quarter 2023 results on Nov 7, after the closing bell....
DaVita (DVA) Expands Operational Footprint Via New Agreement
Zacks via Yahoo Finance· 3 months agoDaVita Inc. DVA recently announced that it has agreed to terms on expanding its international...
DaVita (DVA)'s True Worth: Is It Overpriced? An In-Depth Exploration
GuruFocus.com via Yahoo Finance· 9 months agoDaVita Inc (NYSE:DVA), a leading provider of dialysis services, experienced a daily loss of 4.8% and...
Decoding DaVita Inc (DVA): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 months agoDaVita Inc's dominance in the U.S. dialysis sector with a substantial market share. Strong growth potential in international markets with strategic...
DaVita Inc. Just Beat EPS By 28%: Here's What Analysts Think Will Happen Next
Simply Wall St. via Yahoo Finance· 1 month agoLast week saw the newest first-quarter earnings release from DaVita Inc. (NYSE:DVA), an important...
2 Top-Rated Medical Stocks to Buy After Earnings
Zacks via Yahoo Finance· 1 year agoAs we round out this week’s earnings lineup, a few healthcare companies are standing out after topping their quarterly earnings expectations. Here are...
Don't Overlook These Top Value Stocks in January It's Time to Buy
Zacks via Yahoo Finance· 5 months agoInvestors searching for value will want to pay attention to a few top-rated Zacks stocks that are...
Ozempic's early success in kidney disease trial drags down dialysis stocks
Reuters via Yahoo Finance· 8 months agoShares of dialysis service providers fell sharply on Wednesday after Novo Nordisk's Ozempic showed...
